相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk
Jennifer L. Caswell-Jin et al.
GENETICS IN MEDICINE (2018)
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics
Sarah S. Kalia et al.
GENETICS IN MEDICINE (2017)
ACMG secondary findings 2.0
Leslie G. Biesecker
GENETICS IN MEDICINE (2017)
Higher-than-expected population prevalence of potentially pathogenic germline TP53 variants in individuals unselected for cancer history
Kelvin Cesar de Andrade et al.
HUMAN MUTATION (2017)
The prevalence of DICER1 pathogenic variation in population databases
Jung Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Clinical Variant Classification: A Comparison of Public Databases and a Commercial Testing Laboratory
William Gradishar et al.
ONCOLOGIST (2017)
Lost in translation: returning germline genetic results in genome-scale cancer research
Amber L. Johns et al.
GENOME MEDICINE (2017)
InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines
Quan Li et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2017)
Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium (vol 98, pg 1067, 2016)
Laura M. Amendola et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings
Bryce A. Seifert et al.
CLINICAL CANCER RESEARCH (2016)
An openly available online tool for implementing the ACMG/AMP standards and guidelines for the interpretation of sequence variants
Jeffrey Kleinberger et al.
GENETICS IN MEDICINE (2016)
Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations
Xiaohong R. Yang et al.
HUMAN GENETICS (2016)
Population Frequency of Germline BRCA1/2 Mutations
Kara N. Maxwell et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care
Ella R. Thompson et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Aggregate penetrance of genomic variants for actionable disorders in European and African Americans
Pradeep Natarajan et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Artificial neural networks reveal efficiency in genetic value prediction
L. A. Peixoto et al.
GENETICS AND MOLECULAR RESEARCH (2015)
Frequency and spectrum of actionable pathogenic secondary findings in 196 Korean exomes
Mi-Ae Jang et al.
GENETICS IN MEDICINE (2015)
Assessment of incidental findings in 232 whole-exome sequences from the Baylor-Hopkins Center for Mendelian Genomics
Julie Jurgens et al.
GENETICS IN MEDICINE (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Actionable exomic incidental findings in 6503 participants: challenges of variant classification
Laura M. Amendola et al.
GENOME RESEARCH (2015)
Machine learning applications in genetics and genomics
Maxwell W. Libbrecht et al.
NATURE REVIEWS GENETICS (2015)
ClinGen - The Clinical Genome Resource
Heidi L. Rehm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Secondary findings and carrier test frequencies in a large multiethnic sample
Tomasz Gambin et al.
GENOME MEDICINE (2015)
Identification of Medically Actionable Secondary Findings in the 1000 Genomes
Emily Olfson et al.
PLOS ONE (2015)
The implications of familial incidental findings from exome sequencing: the NIH Undiagnosed Diseases Program experience
Lauren Lawrence et al.
GENETICS IN MEDICINE (2014)
Clinical Interpretation and Implications of Whole-Genome Sequencing
Frederick E. Dewey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma
Jianxin Shi et al.
NATURE GENETICS (2014)
Actionable, Pathogenic Incidental Findings in 1,000 Participants' Exomes
Michael O. Dorschner et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Robert C. Green et al.
GENETICS IN MEDICINE (2013)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
Environment And Genetics in Lung cancer Etiology (EAGLE) study: An integrative population-based case-control study of lung cancer
Maria Teresa Landi et al.
BMC PUBLIC HEALTH (2008)
ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007
C. Sue Richards et al.
GENETICS IN MEDICINE (2008)
The American Cancer Society Cancer Prevention Study II nutrition Cohort - Rationale, study design, and baseline characteristics
EE Calle et al.
CANCER (2002)
Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
PC Prorok et al.
CONTROLLED CLINICAL TRIALS (2000)
分享论文
